As the world's population grows older and the incidence of eye disease increases, the ophthalmic drug market is expanding dramatically. Ophthalmic drugs, which treat a broad array of eye conditions—from minor afflictions such as conjunctivitis to serious diseases like glaucoma and age-related macular degeneration (AMD)—are becoming increasingly integral to modern healthcare. Not...